Open Veils · Answer
Are all vaccines tested against an inert placebo?
The honest answer is: it depends entirely on which vaccine, which trial phase, and how 'inert placebo' is defined — and that definitional dispute is doing enormous work. Many childhood vaccine trials did use saline or sterile-water controls; others used adjuvant-containing formulations or prior vaccine versions as comparators. The core controversy, raised most forcefully by Aaron Siri and RFK Jr., is whether a control containing aluminum adjuvant, polysorbate 80, or other bioactive excipients can legitimately be called 'inert' — and that question has never been definitively settled in peer-reviewed literature.
Evidence
- Aaron Siri, the attorney most closely associated with this challenge, told the CDC's Advisory Committee on Immunization Practices in December 2025 that not one childhood vaccine was licensed based on a truly inert placebo-controlled trial.
- RFK Jr. and the Children's Health Defense have pressed this further: if the control arm receives an aluminum-adjuvanted solution and both arms show similar adverse-event rates, the trial cannot distinguish vaccine-induced harm from adjuvant-induced harm.
- Robert Malone and Peter McCullough have pointed to the accelerated licensure pathway used for COVID-19 mRNA products, where the placebo arm was unblinded and offered the active vaccine within months — effectively ending any long-term controlled comparison.
- His argument hinges on the distinction between a saline control — which contains nothing bioactive — and an 'excipient placebo' containing aluminum salts, surfactants, or stabilizers whose independent immunological and toxicological profiles were never separately tested in long-term safety trials.
- This is not a fringe statistical quibble — it is the same logic the FDA uses when it insists active-ingredient trials isolate the active ingredient.